Atlas Trials

Severe Hepatic Impairment

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Severe Hepatic Impairment

RecordFirmDate
A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction (NCT05224609)Pfizer2022-04-28
An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143 (NCT05199610)EQRx International, Inc.2022-03-30
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients (NCT05116826)Genfit2021-11-05
Evaluate Severe Hepatic Impairment on Dacomitinib PK (NCT03865446)Pfizer2019-04-05
Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects (NCT03818672)Bausch Health Americas, Inc.2019-01-29
PK Study in Subjects With Severe Hepatic Impairment (NCT03664544)Shionogi2018-11-06
Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment (NCT02170220)Takeda2014-07-01
A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men (NCT02138162)Astellas Pharma Europe B.V.2013-08-01

Track Severe Hepatic Impairment automatically

Every clearance here is in the API, with alerts when new ones post.